Rune Kvåle


Rune is an oncology specialist at Haukeland Hospital in Bergen and was employed as a researcher at the Cancer Registry from April 2023. His research interests have primarily focused on clinical registry studies and epidemiology, with both his doctoral and postdoctoral work originating from the Cancer Registry. In the years leading up to his appointment as a researcher at the Cancer Registry, he served as project leader for a research project on cardiovascular diseases after treatment for prostate cancer at the Norwegian Institute of Public Health (FHI). At FHI, he was also responsible for the National Registry of Cardiovascular Diseases (Cardiovascular Registry) from 2015 to 2022. He is a member of the reference group for the "Prostate Cancer Registry," which he helped establish in its early years when it became one of the first national quality registries in Norway in 2004.


Bjerner J, Bratt O, Aas K, Albertsen PC, Fosså SD, Kvåle R, Lilja H, Müller C, Müller S, Stensvold A, Thomas O, Røe OD, Vickers A, Walz J, Carlsson SV, Oldenburg J. Baseline Serum Prostate-specific Antigen Value Predicts the Risk of Subsequent Prostate Cancer Death-Results from the Norwegian Prostate Cancer Consortium. Eur Urol. 2023 May 9:S0302-2838(23)02791-4. doi: 10.1016/j.eururo.2023.04.028. Epub ahead of print. PMID: 37169639.

Forster RB, Engeland A, Kvåle R, Hjellvik V, Bjørge T. Association between medical androgen deprivation therapy and long-term cardiovascular disease and all-cause mortality in nonmetastatic prostate cancer. Int J Cancer. 2022 Oct 1;151(7):1109-1119. doi: 10.1002/ijc.34058. Epub 2022 May 17. Erratum in: Int J Cancer. 2023 Sep 15;153(6):E3. PMID: 35489025; PMCID: PMC9544783.

Kvåle R, Bønaa KH, Forster R, Gravningen K, Júlíusson PB, Myklebust TÅ. Does a history of cardiovascular disease or cancer affect mortality after SARS-CoV-2 infection? Tidsskr Nor Laegeforen. 2020 Dec 29;140(2). English, Norwegian. doi: 10.4045/tidsskr.20.0956. PMID: 33528146.

Kvåle R, Myklebust TÅ, Fosså SD, Aas K, Ekanger C, Helle SI, Honoré A, Møller B. Impact of positive surgical margins on secondary treatment, palliative radiotherapy and prostate cancer-specific mortality. A population-based study of 13 198 patients. Prostate. 2019 Dec;79(16):1852-1860. doi: 10.1002/pros.23911. Epub 2019 Sep 30. PMID: 31566779.